Chronic Recurrent Cutaneous Mucormycosis due to Rhizopus arrhizus.
- Author:
Jae Bok JUN
1
;
Kyung Duck PARK
;
Soon Bong SUH
Author Information
1. Department of Dermatology, Daegu Catholic University School of Medicine, Daegu, Korea. jbjun@cu.ac.kr
- Publication Type:Case Report
- Keywords:
Amphotericin B ointment;
Primary cutaneous mucormycosis;
Rhizopus arrhizus
- MeSH:
Amphotericin B;
Burns;
Diabetes Mellitus;
Humans;
Itraconazole;
Ketoconazole;
Leukemia;
Lymphoma;
Mucormycosis;
Rhizopus;
Skin;
Ulcer;
Young Adult
- From:Korean Journal of Medical Mycology
2008;13(1):31-36
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Mucormycosis occurs primarily in patients with severe underlying illness, especially leukemia, lymphoma, and uncontrolled diabetes mellitus. Cutaneous mucormycosis is somewhat less frequently associated with systemic illness than other forms of mucormycosis. It develops where a break in the integrity of the skin has occurred as a result of surgery, burn, or other forms of trauma. We report herein a case of primary cutaneous mucormycosis due to Rhizopus arrhizus in a 24-year-old healthy man without systemic illness, who developed recurrent, prograssively extending, weeping and tender swollen ulcerative patches at the artificial trauma site on the right side of his face since 9 years of age. It was successfully treated with amphotericin B ointment combined with oral itraconazole and ketoconazole.
